ResearcherNingxia Medical University General HospitalActive in the last 2 years

Xinqing Wang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to target TNFAIP3. Co-author DOI 10.1186/s12885-025-14854-x ↗
RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis. Co-author DOI 10.1186/s40001-024-02261-0 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yongyun Luo · 2 shared papers, 2025 · strength 0.52
- Paper PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to targ… DOI 10.1186/s12885-025-14854-x ↗
- Paper RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis. DOI 10.1186/s40001-024-02261-0 ↗
Qi Wang · 1 shared paper, 2025 · strength 0.27
- Paper PCBP1-AS1 facilitates liver metastasis in pancreatic cancer by modulating miR-125b-5p in Tumor-derived exosomes to targ… DOI 10.1186/s12885-025-14854-x ↗
Jianjun Song · 1 shared paper, 2025 · strength 0.26
- Paper RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis. DOI 10.1186/s40001-024-02261-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.